Financings In the fourth quarter of 2011, biopharma start-ups raised a whopping $693 million – 131% more than Q3. This is the most money generated in this sector since we started running this Quarterl
Exhibit 1 Top Alliances In November 2011 *Potential Deal Value is the sum of up-front fees plus pre-commercialization money Elsevier’s Strategic Transactions Exhibit 2 Top Mergers & Acquisitions In No
In Vitro Diagnostics Mergers & Acquisitions Affymetrix Inc. eBioscience Inc. Genetic analysis company Affymetrix Inc. has signed a definitive agreement to buy private eBioscience Inc. (oncolog